Cargando…

Targeting Ovarian Cancer with IL-2 Cytokine/Antibody Complexes: A Summary and Recent Advances

Detalles Bibliográficos
Autores principales:	Deng, Yilun, Reyes, Ryan M, Zhang, Chenghao, Conejo-Garcia, José, Curiel, Tyler J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035448/ https://www.ncbi.nlm.nih.gov/pubmed/36968176 http://dx.doi.org/10.33696/immunology.3.122

Ejemplares similares

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation
por: Reyes, Ryan M, et al.
Publicado: (2021)

4579 Distinct clinical and immunological responses to αPD-1, kαPD-L1 and αPD-L2 immunotherapy in B16 melanoma in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences
por: Garcia, Myrna G, et al.
Publicado: (2020)

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
por: Bai, Haiyan, et al.
Publicado: (2023)

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
por: Reyes, Ryan Michael, et al.
Publicado: (2021)

Recent Advances in the Inhibition of the IL-4 Cytokine Pathway for the Treatment of Allergen-Induced Asthma
por: Massey, Oliver, et al.
Publicado: (2021)

Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents
por: Murray, Clare, et al.
Publicado: (2022)

Biomarkers for Chronic Pain: Significance and Summary of Recent Advances
por: Eldabe, Sam, et al.
Publicado: (2022)

Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice
por: Garcia, Myrna G., et al.
Publicado: (2022)

421 Specific cephalosporin antibiotics deplete tumor PD-L1 to inhibit DNA damage sensing and sensitize to Chk1 inhibitors in vivo
por: Murray, Clare, et al.
Publicado: (2022)

IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
por: Browning, Landon, et al.
Publicado: (2018)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
por: Gupta, Harshita B, et al.
Publicado: (2016)

Editorial: Recent Advances in Ovarian Stimulation
por: Drakopoulos, Panagiotis, et al.
Publicado: (2022)

Recent Advances in Antibody Therapeutics
por: Heo, Yong-Seok
Publicado: (2022)

Recent Advances in Aptasensor for Cytokine Detection: A Review
por: Kim, Jinmyeong, et al.
Publicado: (2021)

Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
por: Junttila, Ilkka S.
Publicado: (2018)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Recent advances in systemic treatments for ovarian cancer
por: Banerjee, Susana, et al.
Publicado: (2012)

Recent advances in understanding primary ovarian insufficiency
por: Wesevich, Victoria, et al.
Publicado: (2020)

Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody
por: Isozaki, Takeo, et al.
Publicado: (2020)

Recent advances in neutralizing the IL-6 pathway in arthritis
por: Malemud, Charles J
Publicado: (2009)

Recent advances in understanding the role of IL-4 signaling
por: Keegan, Achsah D, et al.
Publicado: (2021)

Immunotherapy Summary for Cytokine Storm in COVID-19
por: Li, Yaqun, et al.
Publicado: (2021)

Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
por: Guan, Qingdong, et al.
Publicado: (2017)

LEP Impedances: Summary Of Recent Measurements
por: Brandt, D, et al.
Publicado: (1992)

A Summary of Recent Work on Vitamines
por: Watson-Wemyss, H. L.
Publicado: (1915)

Cytokine antibody array-based analysis of IL-37 treatment effects in asthma
por: Gao, Shengnan, et al.
Publicado: (2021)

Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma
por: Ezzati, Mohammad, et al.
Publicado: (2014)

Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer
por: Mills, Kathryn, et al.
Publicado: (2017)

Editorial: Recent advances in progestin-primed ovarian stimulation
por: Chen, Qiuju
Publicado: (2022)

Recent advances of bispecific antibodies in solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

Antibody Conjugates-Recent Advances and Future Innovations
por: Leung, Donmienne, et al.
Publicado: (2020)

Antibody–drug conjugates: Recent advances in payloads
por: Wang, Zhijia, et al.
Publicado: (2023)

Recent advances in understanding the complexities of metastasis
por: Chitty, Jessica L., et al.
Publicado: (2018)

Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma
por: Jayant, Kumar, et al.
Publicado: (2020)

Electrochemical Biosensors for Cytokine Profiling: Recent Advancements and Possibilities in the Near Future
por: Dutta, Nirmita, et al.
Publicado: (2021)

Double Agents in the War on Cancer: Leukocytes Govern Ovarian Cancer Progression
por: Scarlett, Uciane K., et al.
Publicado: (2012)

A summary of recent antiprotonic atom experiments
por: Poth, Helmut
Publicado: (1987)

Summary of recent experimental results on strangeness production
por: Kalweit, Alexander
Publicado: (2016)

A Summary of Recent Work on Lobar Pneumonia
por: King, H. H.
Publicado: (1924)

Cannot write session to /tmp/vufind_sessions/sess_2nac5qjhqi33kmribc42ut37b5